What magnitude of ST‑segment depression in millimeters is considered significant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ST-Segment Depression Significance Threshold

Horizontal or downsloping ST-segment depression ≥0.5 mm (0.05 mV) at the J-point in 2 or more contiguous leads is considered significant for myocardial ischemia. 1

Context-Specific Thresholds

The significance of ST-segment depression varies by clinical context:

Acute Coronary Syndrome (Emergency Setting)

  • ≥0.5 mm (0.05 mV) horizontal or downsloping ST depression at the J-point in 2 or more contiguous leads indicates myocardial ischemia and classifies the patient as UA/NSTEMI 1
  • This threshold applies to leads V2-V3 with J-point depression ≥0.05 mV and ≥0.1 mV (1 mm) in all other leads for both men and women 1
  • The morphology matters critically: horizontal and downsloping patterns are pathologic, while upsloping depression requires different interpretation 1

Exercise Stress Testing

  • ≥1.0 mm (0.1 mV) horizontal or downsloping ST depression measured at 60-80 ms after the J-point constitutes a positive test for ischemia 1
  • Upsloping ST depression ≥1.0 mm is considered equivocal (not diagnostically useful for separating normal from abnormal) 1
  • Markedly depressed upsloping ST depression (≥2.0 mm at 80 ms after J-point) may identify underlying CAD in highly symptomatic patients with angina, but this is not generalizable 1

Special Circumstances: Left Bundle Branch Block

  • ≥1 mm concordant ST-segment depression in leads V1-V3 scores 3 points in the modified Sgarbossa criteria and is highly specific for acute MI 1

Critical Measurement Details

Proper measurement technique is essential 1:

  • Measure ST level relative to the end of the PR segment (P-Q junction), not the T-P segment
  • Assess 3 or more consecutive beats in the same lead with stable baseline
  • Measure at 60-80 ms after the J-point for exercise testing 1
  • Measure at the J-point for acute ischemia evaluation 1
  • Visually verify all automated computer measurements 1

Prognostic Significance

The extent of ST depression correlates with outcomes 2:

  • The sum of ST-segment depression across all leads is a powerful independent predictor of 30-day mortality in NSTE-ACS (P<0.0001) 2
  • Greater ST depression correlates with three-vessel disease (P<0.0001), left main disease (P<0.0001), and higher peak creatine kinase levels (P<0.0001) 2
  • However, quantitative assessment beyond presence/absence may not provide incremental value when comprehensive risk stratification (like GRACE score) is already performed 3

Common Pitfalls to Avoid

Do not confuse ST depression patterns 1:

  • ST depression maximal in V1-V4 (versus V5-V6) has 97% specificity for occlusion MI and likely represents posterior wall OMI requiring emergent intervention 4
  • ST depression during supraventricular tachycardia is common (85% of patients) but has only 51% specificity and 6% predictive value for significant CAD 5, 6

Recognize that additional ST depression matters when baseline abnormalities exist 1:

  • When modest resting ST depression is present, only additional ST depression during exercise should be measured for analysis 1
  • In the presence of resting ST elevation from early repolarization, only ST changes below the P-Q baseline should be analyzed 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.